메뉴 건너뛰기
Arthritis Research and Therapy
Volumn 12, Issue 4, 2010, Pages
Bcl-xL affects the development of functional CD4 Tregs
Author keywords

[No Author keywords available]
Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTEIN BCL XL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; BCL2L1 PROTEIN, MOUSE; PROTEIN BCL X;
EID: 78651419768     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3076     Document Type: Letter
Times cited : (3)
References (5)
  • 1
    • 77950638392 scopus 로고    scopus 로고
    • FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development
    • 2888221, 20384988, 10.1186/ar2983
    • Haque R, Lei F, Xiong X, Wu Y, Song J. FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res Ther 2010, 12:R66. 2888221, 20384988, 10.1186/ar2983.
    • (2010) Arthritis Res Ther , vol.12
    • Haque, R.1    Lei, F.2    Xiong, X.3    Wu, Y.4    Song, J.5
  • 2
    • 33745019520 scopus 로고    scopus 로고
    • A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta
    • 1482660, 16735466, 10.1073/pnas.0603201103
    • Sharabi A, Zinger H, Zborowsky M, Sthoeger ZM, Mozes E. A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta. Proc Natl Acad Sci USA 2006, 103:8810-8815. 1482660, 16735466, 10.1073/pnas.0603201103.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 8810-8815
    • Sharabi, A.1    Zinger, H.2    Zborowsky, M.3    Sthoeger, Z.M.4    Mozes, E.5
  • 3
    • 38449119975 scopus 로고    scopus 로고
    • The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model
    • Sharabi A, Luger D, Ben-David H, Dayan M, Zinger H, Mozes E. The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model. J Immunol 2007, 179:4979-4987.
    • (2007) J Immunol , vol.179 , pp. 4979-4987
    • Sharabi, A.1    Luger, D.2    Ben-David, H.3    Dayan, M.4    Zinger, H.5    Mozes, E.6
  • 4
    • 51549118939 scopus 로고    scopus 로고
    • The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells
    • Sharabi A, Mozes E. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells. J Immunol 2008, 181:3243-3251.
    • (2008) J Immunol , vol.181 , pp. 3243-3251
    • Sharabi, A.1    Mozes, E.2
  • 5
    • 75349098582 scopus 로고    scopus 로고
    • Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide
    • 10.1016/j.jaut.2009.06.002, 19596183
    • Sharabi A, Lapter S, Mozes E. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide. J Autoimmun 2010, 34:87-95. 10.1016/j.jaut.2009.06.002, 19596183.
    • (2010) J Autoimmun , vol.34 , pp. 87-95
    • Sharabi, A.1    Lapter, S.2    Mozes, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.